Stock Analysis on Net
Stock Analysis on Net

Biogen Inc. (NASDAQ:BIIB)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 25, 2022.

Common-Size Balance Sheet: Assets
Quarterly Data

Paying user area

Try for free

Biogen Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Biogen Inc., common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel
Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Due from anti-CD20 therapeutic programs
Inventory
Assets held for sale
Other current assets
Current assets
Marketable securities
Property, plant and equipment, net
Operating lease assets
Intangible assets, net
Goodwill
Deferred tax asset
Investments and other assets
Long-term assets
Total assets

Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

Cash and Cash Equivalents
The proportion of cash and cash equivalents as a percentage of total assets demonstrates variability throughout the observed periods. It initially increased from 4.36% in Q1 2017 to a notable peak of 15.75% in Q2 2018, followed by fluctuating decreases and increases, ending at a high of 14.79% in Q3 2022. This suggests periods of increased liquidity management efforts or cash holdings for strategic initiatives.
Marketable Securities (Current)
Marketable securities as a percentage of total assets showed oscillation, beginning at 9.23% in Q1 2017 and generally declining with minor deviations, reaching a low of 4.97% in Q3 2022. This downward trend suggests a reduction in short-term investment holdings or shifts in asset allocation strategy.
Accounts Receivable, Net
Accounts receivable maintained relative stability across the periods, with percentages fluctuating moderately around approximately 7%, from 7.08% in Q1 2017 to 6.31% in Q3 2022. This stability indicates consistent credit sales policies and collection practices.
Due from Anti-CD20 Therapeutic Programs
The balances due from anti-CD20 therapeutic programs remained fairly consistent, fluctuating slightly around the 1.5%-2.3% range of total assets without clear upward or downward trends, reflecting stable related party or programmatic financial arrangements.
Inventory
Inventory levels as a proportion of total assets experienced a continuous rise starting from 4.35% in Q1 2017, dipping slightly mid-period, and then increasing steadily post-2019, reaching 5.53% by Q3 2022. The incremental build-up of inventory may reflect preparations for increased sales demand or changes in supply chain strategies.
Assets Held for Sale
Assets held for sale appeared briefly in Q1 and Q2 2019 at approximately 2.58%-2.60% of total assets, with no further occurrences. This indicates a specific divestiture or planned disposal occurring in that timeframe.
Other Current Assets
Other current assets decreased from 5.81% in Q1 2017 to a low of about 2.32% in Q4 2019, followed by a notable increase reaching 6.56% in Q2 2022 before a slight decline. This suggests variability in other receivables or prepaid expenses, possibly due to operational changes or fluctuating accrued items.
Current Assets
The aggregate current assets as a percentage of total assets showed some volatility, initially around 32-33% in 2017, peaking at 39.29% in Q3 2022. This rise towards the end of the series aligns with the increases in cash, inventory, and other current assets, indicating a growth in liquid and near-liquid holdings.
Marketable Securities (Long-term)
Long-term marketable securities showed a decreasing trend from 13.33% in Q1 2017 to a low near 3.46% in Q3 2022, reflecting a strategic decline in long-term investment assets or reallocations to other asset classes.
Property, Plant and Equipment, Net
Property, plant, and equipment as a proportion of total assets exhibited minor fluctuations but remained relatively stable, centered around the 12%-14% range, indicating steady investment in tangible fixed assets over the period.
Operating Lease Assets
Operating lease assets were recorded starting in Q1 2019, ranging from about 1.28% to 1.76% of total assets through Q3 2022. The slight decline in later periods may reflect lease terminations or changes in lease accounting treatments.
Intangible Assets, Net
Intangible assets showed a declining trend from 19.36% in Q1 2017 to 8.08% by Q3 2022, a considerable decrease suggesting amortization, impairment, or divestitures impacting intangible asset balances.
Goodwill
Goodwill as a percentage of total assets generally increased over the period from 17.04% in Q1 2017 to around 23% in the later years, which may indicate acquisitions and consolidation activities contributing to higher goodwill balances.
Deferred Tax Asset
Deferred tax assets were not present in early periods but emerged in Q4 2017 at 2.52% and increased significantly to near 11.9% by Q4 2019, then decreased to approximately 4.73% in Q3 2022. This pattern reflects changes in tax positions, timing differences, or recognition of deferred tax benefits.
Investments and Other Assets
This category showed considerable variability, starting at 5.59% in Q1 2017, declining substantially by Q4 2017, then rebounding to a peak of 11.78% in Q4 2020, followed by a gradual decline to 6.49% in Q3 2022. The fluctuations may indicate episodic investments or asset reclassifications.
Long-term Assets
Long-term assets as a percentage of total assets showed a general decrease from 67.64% in Q1 2017 to 60.71% in Q3 2022, with intermediate fluctuations. This trend suggests a modest shift in asset composition towards current assets over time.
Total Assets
The total always represents 100% by definition, serving as the base for the proportions assessed.